Windtree Therapeutics, Inc.
WINT
$0.8522
$0.00330.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.79M | -9.71M | -11.38M | -5.96M | -20.29M |
| Total Depreciation and Amortization | 84.00K | 176.00K | 133.00K | 80.00K | 82.00K |
| Total Amortization of Deferred Charges | 97.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.17M | -7.22M | -5.56M | -10.53M | 4.75M |
| Change in Net Operating Assets | 1.37M | 1.46M | 4.12M | 2.55M | 2.02M |
| Cash from Operations | -15.40M | -15.28M | -12.69M | -13.87M | -13.44M |
| Capital Expenditure | -12.00K | -12.00K | -27.00K | -15.00K | -15.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.00K | -12.00K | -27.00K | -15.00K | -15.00K |
| Total Debt Issued | 1.86M | 1.86M | 1.66M | -- | -- |
| Total Debt Repaid | -805.00K | -928.00K | -700.00K | -778.00K | -797.00K |
| Issuance of Common Stock | 14.28M | 10.42M | 2.12M | 12.92M | 12.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -1.88M | -847.00K | -- | -- | -- |
| Total Dividends Paid | -657.00K | -347.00K | -- | -- | -- |
| Other Financing Activities | -68.00K | -68.00K | -168.00K | -100.00K | -- |
| Cash from Financing | 12.73M | 10.09M | 2.92M | 12.04M | 11.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.68M | -5.21M | -9.81M | -1.84M | -1.86M |